NASDAQ NMS - GLOBAL MARKET · KRRO
-3.53% · -$0.5200 · Vol 129.4K
Live · updated 15:54:46 ET
Korro Bio Inc

Korro Bio Inc

Biotechnology
$14.20
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is KRRO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Korro Bio Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
49
Country
US

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$14.72
Day high
$15.16
Day low
$14.00
Previous close
$14.72
52W high
$15.16
-6.33% from high
52W low
$10.47
80% of range
Market cap
$212.3M
EPS
$-8.8400
Shares out
14.4M
Volume
129.4K
VWAP
$14.38
Price history computed in-house
1W
+1.43%
1M
+34.09%
SMA 50 $12.80 · above
SMA 200 $12.80 · above
52W position 80%
Veridion warehouse edge

Warehouse intelligence for KRRO.

Veridion Score
38
0: 451: 522: 543: 104: 785: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

KRRO insider activity

Korro Bio Inc

Score
Coverage building
Pressure
Net buying
Filings
37
Buys / sells
22 / 15
Net value
$46.4M
Insiders
13
Named filers
FF
FORMELA JEAN FRANCOIS
Insider
Leadership
AR
Aiyar Ram
Insider
Leadership
NW
Nichols Weston
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $46.4M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-07-072026-07-06FORMELA JEAN FRANCOISInsidersell$13.968,506146,305$119KSEC Form 4
2026-07-072026-07-06FORMELA JEAN FRANCOISInsidersell$13.96817706,556$11KSEC Form 4
2026-07-072026-07-02FORMELA JEAN FRANCOISInsidersell$14.0314,745154,811$207KSEC Form 4
2026-07-072026-07-02FORMELA JEAN FRANCOISInsidersell$14.0385,955707,373$1.2MSEC Form 4
2026-06-242026-06-24FORMELA JEAN FRANCOISInsidersell$14.98114169,556$2KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 32 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

KRRO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KRRO in this window.
Lobbying spend

KRRO lobbying filings, year to date.

Registered lobbying filings matched to Korro Bio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KRRO in this window.
Latest news · KRRO
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for KRRO.
Options
Sovereign unlock shows live options positioning for KRRO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.